Assessment and Evaluation for Patients with Alcohol Use Disorder: the German Allocation Policy.
Björn Nashan
DOI: https://doi.org/10.1097/tp.0000000000004884
2023-01-01
Transplantation
Abstract:The recent publication of William T. Branagan and J. P. Norvell, Assessment and Evaluation of Alcohol Use Disorder (AUD) in Liver Transplant,1 investigates the experience of the German transplantation scandal2-6 of 2012, as well as the lessons learned and the subsequent implementation of the Guidelines for Liver Transplantation of the German Medical Association (GMA) by 2015.7 Crucial elements in alcohol use disorder (AUD) diagnosis are evaluation and follow-up before and after transplant. Applying a sobriety rule to allow time to take care of patients with AUD in a holistic approach to assess the magnitude of the health problem offers psychosocial support and treatment, including the opportunity of liver transplantation. However, important questions need to be asked. (1) Whom are we going to select? (2) Can we trust in the self-reporting of the patient? (3) Are we free from cultural/social background influences or moral attitudes in making judgment calls? (4) Are we missing underlying psychiatric disorders? (5) What is the impact of the natural history of AUD? These questions do not even address the issue of relapse after transplantation and the guiding principle of responsible selection of recipients in the light of a rare organ source for transplantation. Part of the 2012 German scandal in liver, heart, and lung transplantation was the lack of scientific evidence of the existing guidelines. The interpretation and decision-making process were left to the directors of the transplant programs. There were no interdisciplinary selection committees or need for documentation, with the exception of the Abdominal Transplant Center in Hamburg.2 Hence, transparency and accountability of the decision-making process were completely absent; the guiding principle was to trust those who made the decisions. Once the audit process of the transplant centers began, a surprising abuse of trust was found, particularly by high-ranking individuals within the system, including the former president of Eurotransplant.3-6 Rather than changing the guidelines of the committees of which they had been members or even raising the issue to these committees, they promoted the idea of being able to follow a different interpretation of the guidelines. In liver transplantation, 3 main abuses were seen: (1) forging dialysis or creatinine values, (2) transplanting AUD patients or acute on chronic liver failure in patients with AUD without appropriate assessment or following the 6-mo sobriety rule in place at that time, and (3) “personalized” readings of imaging in patients with hepatocellular carcinoma. Items 1 and 3 were addressed by making forgery of files a felony instead of a minor offense and by adopting the United Network for Organ Sharing Liver Imaging Reporting and Data System to the diagnosis of hepatocellular carcinoma, respectively.2,7,8 Item 2 was more demanding because the 6-mo sobriety rule existing at that time did not comply with German law; it had been rejected by the Bundesgerichtshof (Federal Court of Justice) on June 28, 2017.9 As a consequence, the guidelines for AUD were completely revised. To reorganize procedures and in anticipation of the forthcoming verdict of the Bundesgerichtshof, the Permanent Committee for Organ Transplantation at the GMA updated, in a stepwise manner, the guidelines of the GMA for Organ Transplantation between 2012 and 2015 to be in line with the existing legal and structural requirements of the German Transplantation Legislation as follows2: An Interdisciplinary Transplantation Conference was introduced in accordance with the standard operating procedures of the Abdominal Transplantation Center in Hamburg (December 14, 2012).2,7,8 Guidelines are now drafted in the organ committees of the German Transplantation Society, discussed and finalized in working groups of the Permanent Committee on Organ Transplantation (StäKO), and sent out for public comment with final approval by the StäKO, the Board of the GMA, and the Ministry of Health.2,7,8 In the case of the guidelines for AUD, additional approval needs to be given by the Ministry of Justice. The aim was to achieve accountability and transparency in documentation and reporting.7,8 The new guidelines for AUD were first implemented on June 30, 2015,7 and some excerpts of those guidelines are included below. “I.5 General principles for listing on the organ transplant waiting list ….The members of the interdisciplinary transplantation conference are to be named to the Allocation Center (Eurotransplant) and are responsible for all allocation-related reports and decisions. In particular, they sign the decision to list a patient on the waiting list and submit the document as the basis for registration to the Allocation Agency (Eurotransplant). The medical leadership of the clinic must also be informed in writing, including any deviating statements. If necessary, a vote from an external transplant conference can be obtained.” “III.5 Composition of the interdisciplinary transplantation conference The interdisciplinary transplantation conference according to Chapter I, Item 5 of the general part of these guidelines is made up of representatives of the involved surgical and conservative disciplines (head or his/her representative). They must be board certified in transplantation medicine (Zusatzweiterbildung Transplantationsmedizin10) or must have equivalent experience, as long as the training regulations of the respective state medical association do not provide for this board certification. Representatives are one each: • Specialist in visceral surgery with additional training in special visceral surgery or comparable experience • Specialist in internal medicine and gastroenterology or in pediatrics • Specialist in pediatric and adolescent medicine with additional further training in children and adolescent gastroenterology • Specialists in anesthesiology or in the fields of surgery, internal medicine or child and adolescent medicine, each with additional training in intensive care medicine and one each: • Representatives of another medical discipline that is not directly involved in the transplantation process nominated by the medical leadership of the clinic • Mental Health Professional (not required for pediatric patients) Depending on the clinical picture of the patient, representatives of other medical disciplines such as e.g.: • Specialist in internal medicine and nephrology • Specialist in internal medicine and hematology and oncology • Radiology Specialist are to consult. In addition, a representative of nursing or the transplantation coordination can participate in an advisory capacity in the transplant conference. The allocation-relevant findings, including the laboratory values confirmed by the responsible specialists for laboratory medicine, must be checked for plausibility and confirmed by the regular interdisciplinary transplantation conference.” The guidelines for AUD are summarized as follows7,8: “II 2.1 Alcohol associated cirrhosis In patients with alcohol-associated cirrhosis, also in combination with other liver diseases (e.g., HCC) or as part of other liver diseases (e.g., HCV, HBV), the patient will only be listed on the waiting list if the patient’s medical history has shown complete abstinence from alcohol for at least 6 months. - Ethyl glucuronide in urine (uEtG; positive if > 0.5 mg/l with LC-MS/MS) is determined as a laboratory parameter for assessing alcohol consumption. Additionally, or if a uEtG determination is not possible for medical reasons, ethyl glucuronide in hair (hEtG) and carbohydrate-deficient transferrin (CDT) can be used for assessment. - To assess possible addictive behavior (harmful use) and the patient’s willingness and ability to adhere to treatment agreements, an opinion is obtained from a mental health professional and considered under the aforementioned laboratory parameters. - This statement also contains suggestions for further addiction therapy care or treatment. During the time on the waiting list, regular laboratory checks are done, including the laboratory parameters mentioned above. Urine ethyl glucuronide, possibly in combination with other alcohol markers, is tested at least every 3 months as part of an outpatient visit of the patient. If the patient continues to consume alcohol, the transplant conference must report the patient as “nontransplantable” (NT) and re-evaluate. This includes a renewed transplant-related diagnosis by a mental health professional and, if necessary, therapeutic intervention. In justified exceptional cases, which are particularly present in the case of acute decompensated alcoholic liver disease, where there is a need and a chance of success for transplantation, the interdisciplinary transplantation conference can decide to deviate from the rule that the patient has abstained completely from alcohol for at least 6 months. The prerequisite is that the group of experts has given its opinion in accordance with Chapter III.9 of these guidelines.” “III.9 Composition of the expert group and procedures for alcohol associated liver cirrhosis The panel of experts consists of 3 physicians experienced in liver transplantation (1 transplant surgeon, 1 specialist in internal medicine and gastroenterology, 1 mental health professional) from different centers in the area of the GMA, but not from the notifying center. The members of the group of experts are nominated by the Permanent Commission on Organ Transplantation and used by the Allocation Agency (Eurotransplant) to assess exceptional cases (see Section III.2.1). In order for the Allocation Agency (Eurotransplant) to be able to act, the patient must be reported to the Allocation Agency. For this purpose, until the final listing decision is made, he will receive the nontransplantable (NT) status. The expert opinion of the expert group follows immediately; it does not bind the decision-making of the interdisciplinary transplant conference but supports it. The statement is documented by the Allocation Agency, which also forwards it to the Permanent Commission on Organ Transplantation. The group of experts regularly reports to the Permanent Commission on Organ Transplantation regarding the exceptional cases it has assessed. Based on these, proposals for the further development of this guideline are developed.” Patients with AUD-related cirrhosis (K70 International Statistical Classification of Diseases and Related Health Problems) who received liver transplantation represented 20% to 22% of the recipients between 2013 and 202111; the implementation of the new guidelines had no effect on patient selection for the waitlist. In summary, in addition to introducing an accountable framework in reporting, the specific changes in the guidelines for patients with AUD include consultation with a professional in mental health, follow-up, and provision of therapy options other than transplantation. Informed consent from the patient is mandatory for all procedures. Access to liver transplantation in cases of acute liver failure due to alcoholic hepatitis or acute on chronic liver failure as documented by the Interdisciplinary Transplantation Conference has been made available. A second opinion has to be officially requested in these cases but shall not influence the decision of the Interdisciplinary Transplantation Conference.12 In fact, the 6-mo sobriety rule has become part of a larger framework introduced to manage the treatment of patients with AUD, but it is no longer a barrier for access to liver transplantation in patients with AUD-based cirrhosis in either acute on chronic liver failure or acute liver failure related to acute alcoholic hepatitis.